Here is a closer look at the recent #JITC short report, "Multi-institutional Analysis of Aneuploidy & Outcomes to Chemoradiation & Durvalumab in Stage III NSCLC" 1/11 The clinical implications of aneuploidy and correlation with outcomes to concurrent chemoradiation (cCRT) and durvalumab in Stage III NSCLC are poorly understood. In this retrospective analysis, the authors aimed to better understand this link. 2/11

Meet the Author: Emily Hoffmann (@Emily__Hoffmann), med student w/ @CorneliusFaber & @HelfenLab groups from @WWU_Muenster & @UK_Muenster, is 1st author of “Profiling specific cell populations w/in the inflammatory TME by oscillating-gradient diffusion-weighted MRI”, in #JITC! 1/6 She was inspired to pursue research during her first clinical traineeship in radiology when she realized the routine clinical imaging approaches had not kept pace with the rapid development of novel targeted cancer therapies. 2/6

Meet the Author: Alexandra Beckett (@itsalexbeckett), a PhD candidate and #ECR from St. Jude Children’s Research Hospital @StJudeResearch @stjudegraduate, is 1st author of “CD47 expression is critical for CAR T cell survival in vivo”, recently published in #JITC! 1/7 She was inspired to become a researcher to combine her drive to constantly learn with her desire to make a positive impact in the world by developing novel cancer therapies. 2/7